Abstract | AIM: PATIENTS AND METHODS: RESULTS: The clinical characteristics of the groups were not significantly different (p > 0.05). The percentage of patients whose thrombolysis in myocardial infarction (TIMI) myocardial perfusion grades were less than 3 was significantly higher for group B than for group A (13.9 vs. 3.8 %, p = 0.029). The infarct size on cardiac magnetic resonance imaging was significantly different between groups (p = 0.036). At 6 months after the operation, the echocardiography results were better for patients in group B than for those in group A (p = 0.024 and p = 0.016, respectively). The frequency of bleeding complications and major adverse cardiac events of the groups were not significantly different (p > 0.05). CONCLUSION:
|
Authors | T Geng, J-G Zhang, Z-Y Song, S-P Dai, Y Luo, Z-S Xu |
Journal | Herz
(Herz)
Vol. 41
Issue 8
Pg. 732-740
(Dec 2016)
ISSN: 1615-6692 [Electronic] Germany |
Vernacular Title | Aspirationsthrombektomie und intrakoronare Tirofibangabe bei ST-Hebungs-Infarkt : Kombinationstherapie bei Patienten mit primärer perkutaner Koronarintervention. |
PMID | 27220978
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Fibrinolytic Agents
- Tyrosine
- Tirofiban
|
Topics |
- China
(epidemiology)
- Combined Modality Therapy
(mortality, statistics & numerical data)
- Female
- Fibrinolytic Agents
(administration & dosage)
- Humans
- Male
- Middle Aged
- Percutaneous Coronary Intervention
(mortality, statistics & numerical data)
- Prevalence
- Risk Factors
- ST Elevation Myocardial Infarction
(diagnosis, mortality, therapy)
- Survival Rate
- Thrombectomy
(mortality, statistics & numerical data)
- Tirofiban
- Treatment Outcome
- Tyrosine
(administration & dosage, analogs & derivatives)
|